Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia

American Journal of Epidemiology

Volumn 162, Issue 12, 2005, Pages 1198-1206

  Bodnar, Lisa M ^a,b   Ness, Roberta B ^a,b,c   Harger, Gail F ^a,b   Roberts, James M ^a,b,c  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Body mass index; C reactive protein; Inflammation; Obesity; Pre eclampsia; Pregnancy; Triglycerides

Indexed keywords

C REACTIVE PROTEIN; TRIACYLGLYCEROL;

BODY MASS; PREGNANCY;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CALCULATION; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GESTATION PERIOD; HUMAN; INFLAMMATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OBESITY; PREECLAMPSIA; PREGNANCY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

ADULT; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; INFLAMMATION; LOGISTIC MODELS; OBESITY; PENNSYLVANIA; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TRIGLYCERIDES;

EID: 28944441944     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwi334     Document Type: Article

References (40)

1. Roberts JM. Pregnancy-related hypertension. In: Creasy RK, Resnik R, eds. Maternal-fetal medicine. Philadelphia, PA: W B Saunders Company, 1998:833-72.
2. Bodnar LM, Ness RB, Markovic N, et al. The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol 2005;15:475-82.
3. Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA 1991;266:237-41.
4. Mittendorf R, Lain KY, Williams MA, et al. Preeclampsia: a nested, case-control study of risk factors and their interactions. J Reprod Med 1996;41:491-6.
5. O'Brien TE, Ray JG, Chan WS. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 2003;14:368-74.
6. Sibai BM, Ewell M, Levine RJ, et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1997;177:1003-10.
7. Thadhani R, Stampfer MJ, Hunter DJ, et al. High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy. Obstet Gynecol 1999;94:543-50.
8. Chan DC, Barrett HP, Watts GF. Dyslipidemia in visceral obesity: mechanisms, implications, and therapy. Am J Cardiovasc Drugs 2004;4:227-46.
9. Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282:2131-5.
10. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999;180:499-506.
11. Hubel CA. Dyslipidemia, iron, and oxidative stress in preeclampsia: assessment of maternal and feto-placental interactions. Semin Reprod Endocrinol 1998;16:75-92.
12. Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998;16:5-15.
13. Ness RB, Markovic N, Bass D, et al. Family history of hypertension, heart disease, and stroke among women who develop hypertension in pregnancy. Obstet Gynecol 2003;102:1366-71.
14. Ness RB, Roberts JM. Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 1996;175:1365-70.
15. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report. Obes Res 1998;6(suppl 2):51S-209S.
16. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183(suppl):S1-22.
17. Neithardt AB, Dooley SL, Borensztajn J. Prediction of 24-hour protein excretion in pregnancy with a single voided urine protein-to-creatinine ratio. Am J Obstet Gynecol 2002;186:883-6.
18. Levine RJ, Esterlitz JR, Raymond EG, et al. Trial of Calcium for Preeclampsia Prevention (CPEP): rationale, design, and methods. Control Clin Trials 1996;17:442-69.
19. Levine RJ, Hauth JC, Curet LB, et al. Trial of calcium to prevent preeclampsia. N Engl J Med 1997;337:69-76.
20. Kluft C, de Maat MP. Sensitive markers of inflammation make it possible to study the chronic process: the rise of interest in low levels of C-reactive protein. Vascul Pharmacol 2002;39:99-104.
21. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998;81:7B-12B.
22. Bureau of the Census, US Department of Commerce. Poverty in the United States: 1990. Series P-60. Washington, DC: Bureau of the Census, 1991.
23. Cole SR, Hernán MA. Fallibility in estimating direct effects. Int J Epidemiol 2002;31:163-5.
24. Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology 1990;10:37-48.
25. Pearl J. Causal diagrams for empirical research. Biometrika 1995;82:669-88.
26. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
27. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
28. Qiu C, Luthy DA, Zhang C, et al. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia. Am J Hypertens 2004;17:154-60.
29. Wolf M, Kettyle E, Sandler L, et al. Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol 2001;98:757-62.
30. Williams MA, Farrand A, Mittendorf R, et al. Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol 1999;149:323-9.
31. Sacks GP, Studena K, Sargent K, et al. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstet Gynecol 1998;179:80-6.
32. Djurovic S, Clausen T, Wergeland R, et al. Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia. BJOG 2002;109:759-64.
33. Levine RJ, Qian C, Leshane ES, et al. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 2004;190:707-13.
34. Clausen T, Djurovic S, Henriksen T. Dyslipidemia in early second trimester is mainly a feature of women with early onset pre-eclampsia. BJOG 2001;108:1081-7.
35. Chappell LC, Seed PT, Briley A, et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002;187:127-36.
36. Gratacos E, Casals E, Sanllehy C, et al. Variation in lipid levels during pregnancy in women with different types of hypertension. Acta Obstet Gynecol Scand 1996;75:896-901.
37. Lorentzen B, Endresen MJ, Clausen T, et al. Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia. Hypertens Pregnancy 1994;13:103-9.
38. Ramsay JE, Ferrell WR, Crawford L, et al. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 2002;87:4231-7.
39. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem 2004;279:48487-90.
40. Institute of Medicine, National Academy of Sciences. Nutrition during pregnancy. Washington, DC: National Academy Press, 1990.